Cargando…
Treatment of Acquired von Willebrand Disease due to Extracorporeal Membrane Oxygenation in a Pediatric COVID-19 Patient with Vonicog Alfa: A Case Report and Literature Review
Acquired von Willebrand disease (aVWD) is frequently observed in patients with the need for extracorporeal membrane oxygenation (ECMO). aVWD can be treated by plasma-derived concentrates containing factor VIII (FVIII) and/or von Willebrand factor (VWF) and recombinant VWF concentrate as well as adju...
Autores principales: | Heubner, Lars, Trautmann-Grill, Karolin, Tiebel, Oliver, Mirus, Martin, Güldner, Andreas, Rand, Axel, Spieth, Peter Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949976/ https://www.ncbi.nlm.nih.gov/pubmed/36846831 http://dx.doi.org/10.1055/a-2008-4367 |
Ejemplares similares
-
Type 2A von Willebrand disease and systemic sclerosis: Vonicog alfa reduced gastrointestinal bleeding
por: Korsten, Peter, et al.
Publicado: (2020) -
Extreme obesity is a strong predictor for in-hospital mortality and the prevalence of long-COVID in severe COVID-19 patients with acute respiratory distress syndrome
por: Heubner, Lars, et al.
Publicado: (2022) -
Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study
por: Heubner, Lars, et al.
Publicado: (2022) -
Shear-induced acquired von Willebrand syndrome: an accomplice of bleeding events in adults on extracorporeal membrane oxygenation support
por: Wang, Haiwang, et al.
Publicado: (2023) -
Acquired von Willebrand syndrome: focused for hematologists
por: Franchini, Massimo, et al.
Publicado: (2020)